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Guoqing Chen1,2,3, Limin Liao1,2,3* and Di Miao1,2,3Abstract
Background: A previous study showed that foot stimulation can delay the bladder filling sensation and increase
bladder volume in healthy humans without OAB. The aim of this study was to determine whether or not electrical
stimulation of somatic afferent nerves in the foot can increase bladder capacity in neurogenic bladder patients after
sigmoid cystoplasty.
Methods: Eleven subjects underwent 30-min foot stimulation using skin surface electrodes connected to a
bladder-pelvic stimulator. The electrodes were attached to the bottom of the foot. The subjects completed a
5-day voiding diary, during which time foot stimulation was applied on day 3. The stimulation parameter was a
continuous, bi-polar square wave form with a pulse duration of 200 μs and a stimulation frequency of 5 Hz. The
stimulation intensity was set by each subject at a maximal level without causing discomfort.
Results: The volume per clean intermittent catheterization (CIC) was 279.4 ± 11.7 ml and 285.4 ± 11.8 ml on the
1st and 2nd days, respectively. On the 3rd day, the average volume per CIC increased to 361.1 ± 18.1 ml after
stimulation (p <0.05). The average volume per CIC returned to 295.4 ± 13.4 ml and 275.1 ± 11.5 ml on the 4th and
5th days, respectively.
Conclusions: Foot stimulation can delay the bladder filling sensation and significantly increase bladder capacity in
neurogenic bladder patients after sigmoid cystoplasty.
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Augmentation enterocystoplasty (AE) is the reference
standard for patients with neurogenic bladder dysfunc-
tion (NBD) with the detrimental effects of high-bladder
pressure on the upper urinary tract (UUT). The purpose
of AE is to create a large-capacity, low-pressure, good-
compliance reservoir with a preserved UUT, thus allow-
ing for socially-acceptable continence [1]. Based on our
previous research [1], we found that incontinence still
occurred and bladder capacity was unsatisfactory within
6 months following sigmoid cystoplasty in some patients
because of the weakened function of the sphincter, auto-
matic contraction of the intestinal reservoir, and residual* Correspondence: lmliao@263.net
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unless otherwise stated.detrusor overactivity (DO) post-operatively. Therefore,
we asked these patients to use oral anti-cholinergic
agents until the bladder capacity increased and had good
compliance.
A previous study showed that foot stimulation using
skin surface electrodes inhibits DO and has a long-
lasting effect in cats [2], likely as a result of stimulating
branches of the tibial nerve in the foot. Recently, Chen
[3] reported that foot stimulation can also delay the
bladder filling sensation and increase bladder volume in
healthy humans without OAB.
In the current study we reported the initial outcome
of a clinical study in which we evaluated the effective-
ness of electrical stimulation of somatic afferent nerves
in the feet of neurogenic bladder patients who emptied
the bladder by clean intermittent catheterization (CIC)
after sigmoid cystoplasty.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Chen et al. BMC Urology  (2015) 15:26 Page 2 of 5Methods
This study was approved by the Ethics Committee of the
China Rehabilitation Research Center. All participants
signed an informed consent. Foot stimulation was tested
in 11 neurogenic bladder patients after sigmoid cysto-
plasty (7 males, 4 females; mean age, 28.9 ± 3.3 years;
age range, 17–46 years) who used CIC to empty the
bladder. All the patients were ≥ 1 month post-sigmoid
cystoplasty (mean, 4.6 ± 1.2 months; duration, 1–12
months) for neurogenic bladder refractory to conserva-
tive treatment. Intra-operatively, a 20–30 cm segment of
sigmoid colon was isolated with its vascular pedicle and
opened on the anti-mesenteric border to form a patch.
The detubulized sigmoid patch was sutured onto the
opened bladder. After recovering from surgery, the cap-
acity was increased from 105.6 ± 10.2 ml pre-operatively
to 280.5 ± 11.7 ml by urodynamic evaluation. Then the
patients were instructed to empty the bladder by CIC
for life. Before surgery, all of the patients were diagnosed
with incomplete spinal cord damage based on American
Spinal Injury Association (ASIA) standards [4] and elec-
trophysiologic assessment.
The subjects were instructed to record CIC volumes
during a 5-day period without restriction of daily food
and water intake when they returned to the hospital for
a follow-up evaluation. The subjects were also instructed
to perform CIC when urine leaked or in response to the
usual bladder sensations in patients in whom bladder
sensations still existed. Foot stimulation was applied for
30 minutes in the morning (9:00–9:30 a.m.) on day 3
with the subject in the sitting position. Two skin surface
electrodes (4 × 4 cm) were attached to the plantar sur-
faces of both feet. A cathodal electrode was placed on
the anterior aspect of the foot and an anodal electrode
was placed between the inner foot arch and the heel. The
two pairs of electrodes were connected to a bladder-pelvic
stimulator [Bladder-Pelvic Stimulator (I) developed by
Neural Electro-Mechanics Center of Chinese Academy
Sciences and Dept. of Urology at China Rehabilitation
Research Center, and supported by the China National
Technology R&G Program].
The Bladder-Pelvic Stimulator (I) consists of three
sub-systems (stimulation circuit, user interface device,
and electrode adaptor; Figure 1). The stimulator sup-
ports four independent output channels. The stimulator
can generate mono- and bi-polar pulse wave with user-
defined waveforms and parameters as follows (step sizes
are given in parentheses): pulse amplitude 1–50 mA
(0.5 mA); pulse frequency 1–100 Hz (1 Hz); pulse width
50–2000 μs (10 μs); pulse train duration 0.1 – 10 s
(0.1 s); pulse train interval 0 – 10s (0.1 s); pulse train ris-
ing edge 0 – 10s (0.1 s); and pulse train falling edge 0.01 –
10 s (0.1 s). The user interface was developed on the
android tablet platform. Clinicians can select and modifystimulation parameters on the tablet. The electrode inter-
face supports multiple types of implantable and surface
electrodes, which were not included in this study.
The stimulation applied in this study was a continu-
ous, bipolar square wave form with a pulse duration of
200 μs and a stimulation frequency of 5 Hz. The stimu-
lator was controlled to determine the minimal current
needed to induce a toe twitch. The stimulation intensity
was then increased to the maximal level, which was
comfortable for the subject during the entire 30-min
stimulation. The volume per CIC was averaged among
subjects during 5 periods, as follows: 1) 48–24 hours be-
fore foot stimulation; 2) 24 hours before foot stimula-
tion; 3) up to 24 hours after stimulation; 4) 24–48 hours
after stimulation; and 5) 48–72 hours after stimulation.
One-way ANOVA, followed by the Dunnett multiple
comparison test, was used to detect statistically signifi-
cant differences (p <0.05) between voided volumes be-
fore and after stimulation.
Results
The baseline characteristics and the stimulation inten-
sities of the patients are shown in Table 1.
The volume per CIC was 279.4 ± 11.7 ml and 285.4 ±
11.8 ml during the 1st and 2nd periods, respectively.
During the 3rd period, the average volume per CIC in-
creased to 361.1 ± 18.1 ml after stimulation (p <0.05;
Figure 2). The average volume per CIC returned to
295.4 ± 13.4 ml and 275.1 ± 11.5 ml in the 4th and 5th
periods, respectively.
The volume per CIC remained increased for 24 h after
stimulation in all of the patients. Subjects 4 and 7 had
greater bladder capacities 24–48 h after stimulation than
before stimulation. Forty-eight hours after stimulation,
the volume per CIC returned to pre-stimulation baseline
in all patients. Subject 3, who was 1 month post-surgery,
felt a desire to void when the capacity was approximately
190 ml, but the bladder filling sensation was delayed and
the bladder volume was increased to 246.0 ± 18.3 ml
after stimulation.
All subjects tolerated stimulation without discomfort.
There were no immediate or long-term adverse events
associated with stimulation.
Discussion
In the current study all of the patients underwent sigmoid
cystoplasties for 1–12 months (mean, 4.6 ± 1.2 months)
because of a neurogenic bladder secondary to incomplete
spinal cord injuries, meningoceles, or spina bifida. After
recovering from surgery, the patients were asked to empty
their bladders by CIC; however, the mean bladder capacity
was only 280.5 ± 11.7 ml at early follow-up post-
operatively based on urodynamic evaluation, which was
unsatisfactory for those subjects who had undergone
Figure 1 The picture of the Bladder-Pelvic Stimulator (I).
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that the most common problem within 6 months post-
operatively was incontinence, which might have re-
sulted from the weakened function of the sphincter
post-operatively. The presence of an indwelling urethral
catheter for a long period could contribute to sphincter
weakness because the maximal urethral pressure at rest
was significantly decreased during the 6-month follow-
up examination compared with the pre-operative pres-
sure. Automatic contraction of the intestinal reservoir
could also lead to pressure increase and incontinence.
The residual detrusor also may maintain DO post-
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11-M-30 Meningocele 12 25 20reduced bladder compliance. The aforementioned four
reasons can explain why the bladder capacity of the pa-
tients in the current study was not satisfactory at the
early follow-up evaluation. The patients continued to
use CIC combined with oral anti-cholinergic agents
until the bladder capacity became larger 6 months post-
operatively. The anti-cholinergic agents have some side
effects, e.g., dry mouth, thus the patients cannot take
the medications for a long time.
Previous studies in cats showed that transcutaneous
electrical stimulation of somatic afferent nerves in the foot
inhibits reflex micturition, significantly increases bladder
capacity [5], and induces post-stimulation inhibition ofefore and after stimulation
Mean ± SE Vol/CIC (ml)




Up to 24 h
after
24 ~ 48 h
after
48 ~ 72 h
after
263.3 ± 68.4 266.7 ± 66.7 300.0 ± 57.7 266.7 ± 44.1 270.0 ± 65.1
310.0 ± 5.8 305.0 ± 9.6 410.0 ± 23.8 290.0 ± 5.8 302.5 ± 13.2
190.0 ± 4.2 191.7 ± 4.4 246.0 ± 18.3 210.0 ± 7.7 200.0 ± 4.1
291.7 ± 41.7 286.7 ± 21.1 400.0 ± 60.2 358.0 ± 58.9 253.3 ± 36.9
246.7 ± 42.2 260.0 ± 19.2 302.9 ± 21.8 240.0 ± 24.7 258.3 ± 33.5
300.5 ± 33.7 315.0 ± 26.8 385.5 ± 41.2 320.0 ± 38.4 305.8 ± 29.1
286.0 ± 62.3 300.0 ± 35.8 344.0 ± 50.4 325.0 ± 41.1 253.3 ± 27.7
266.0 ± 15.7 271.4 ± 19.6 364.0 ± 45.8 291.7 ± 14.2 261.7 ± 25.6
310.0 ± 17.0 328.6 ± 19.6 424.0 ± 31.2 325.0 ± 41.1 320.0 ± 13.7
276.0 ± 12.9 285.7 ± 12.3 352.0 ± 8.6 281.7 ± 5.4 265.0 ± 5.6
334.0 ± 6.8 328.6 ± 19.6 444.0 ± 11.7 341.7 ± 11.7 336.7 ± 14.1
Figure 2 Mean bladder volume per CIC measured in 11
subjects during 48–24 h, 24 h before foot stimulation (Stim),
and within 24 h, during 24–48 h and 48–72 h after foot
stimulation at 5 Hz frequency, 200 μs pulse width, and
15–50 mA intensity. Asterisks indicate significantly different versus
voided volume before stimulation (p <0.05).
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the same mechanisms might occur in healthy humans. It
has been demonstrated that transcutaneous electrical
stimulation of somatic afferent nerves in the foot can delay
bladder filling sensations and significantly increase bladder
capacity > 50% in healthy humans, and this technology has
the potential to be an effective new treatment for patients
with DO [3].
In our study, foot stimulation using skin surface elec-
trodes also can delay the bladder filling sensation and
significantly increase bladder capacity (Table 1 and
Figure 1) in the patients after sigmoid cystoplasty. The
volume per CIC was significantly increased compared
with baseline, and this effect can last > 1 day.
The mechanism underlying foot stimulation is un-
known, but may be mediated by the nerve in the foot
[3]. The stimulation electrodes were placed on the skin
surface rather than directly on the nerves. Which nerves
were activated? The tibial nerve courses from the inner
ankle inferiorly to the plantar surface of the foot and
branches into the lateral and medial plantar nerves at
the location of the electrodes. These nerves further
branch into multiple small nerves that course toward
the toes. Thus, it is highly likely that foot stimulation ac-
tivates afferent branches of the tibial nerve in the lateral
and medial plantar aspects of the foot.
The spinal segmental distribution of the stimulated
somatic afferent pathways is an important factor in the
efficacy of this type of neuromodulation [5]; however, in-
hibition at a supraspinal site cannot be excluded. A pre-
vious study in cats showed that the inhibitory effect on
bladder activity elicited by electrical stimulation of the
nerves from the hind limb muscles was lost after chronicspinal cord transection at the thoracic level, indicating a
possible role of the supraspinal mechanisms in somato-
vesical inhibition [6]. In the current study, all of the pa-
tients had incomplete spinal cord damage; therefore we
cannot confirm whether or not foot stimulation has the
same effects in patients with complete spinal cord dam-
age. The Chen study [3] showed that some subjects
voided a larger volume after only 30 minutes of stimula-
tion, indicating that 30 minutes of stimulation might be
sufficient to induce an inhibitory effect; thus, foot stimu-
lation was applied for only 30 minutes in the current
research.
In the Chen study [3], the average voided volume in-
creased by > 50% or approximately 200 ml, which is
more than the increase (approximately 30%) in volume
per CIC in the current study. We calculated the mean
volume per CIC in 24 hours after stimulation during the
3rd period, which was > 5 hours in the Chen study [3]. It
is well known that the stimulation effect will weaken
over time. Thus, if we also calculate the average volume
per CIC 5 h after stimulation, the result may be close to
the volume reported by Chen [3].
Although only a few subjects with neurogenic bladder
secondary to incomplete spinal cord injuries, meningo-
celes, or spina bifida were tested in the study who used
CIC to empty the bladder post-sigmoid cystoplasty, our
results support proceeding with clinical trials involving
foot stimulation in patients with OAB and other types of
neurogenic bladder. Currently, CIC combined with an
anti-cholinergic medication is the gold standard treat-
ment for NDO; however, many patients are refractory to
the medication or have dose-limiting side effects [7]. If
foot stimulation can inhibit DO, improve bladder com-
pliance, and increase bladder capacity in patients with
neurogenic bladder, foot stimulation can be used to treat
the patients instead of anti-cholinergic medications.
This is the first clinical trial in which electrical stimu-
lation of the foot was used to treat patients. We want to
determine whether or not this treatment can increase
the bladder capacity in patients. Although a positive ef-
fect was shown in the current study, there were some
flaws and limitations in the study. In the future, we need
to conduct a randomized controlled trial to further elu-
cidate and confirm our findings. First, the subjects in the
current study all had meningoceles, incomplete spinal
cord injuries, or spina bifida who had undergone sig-
moid cystoplasties for 1–12 months and they do not
represent all types of lower urinary tract disorders, thus
we need to continue investigating patients with OAB
and other types of neurogenic bladder. Second, we only
focused on the changes of volume per CIC; CIC times
and the urodynamic data after stimulation require study
to verify the effect. Third, additional studies with a larger
number of subjects are required to determine the
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date the post-stimulation effect. Fourth, the neobladder
is composed of the residual bladder and sigmoid, still it
is not known whether the capacity increased due to re-
sidual bladder or the sigmoid from the current data. It is
difficult to prove in an augmentation model unless a
pre-AE stim response is also recorded; alternatively, a
similar study on orthotopic neobladder can also answer
the question of whether detubularized bowel can re-
spond to peripheral stimulation. However, no pre-
augmentation stim was performed in this study. Though
it is verified that neuromodulation is effective for both
bladder and bowel dysfunction in previous literature [8],
we still need to perform some studies to answer above-
mentioned questions in the future. Fifth, all of the pa-
tients underwent this procedure at our medical center,
but we are designing a portable bladder-pelvic stimulator
so that patients can operate it in their own homes.
Conclusions
Electrical stimulation of the foot using skin surface elec-
trodes can delay the bladder filling sensation and signifi-
cantly increase bladder capacity in neurogenic bladder
patients after sigmoid cystoplasty. Thus, foot stimulation
will be a promising treatment option if it is shown to be
clinically effective in OAB and NDO in the future because
it is non-invasive and can be easily managed by patients.
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